https://theexpertindex.ai/experts/healthcare/benjamin-katzBenjamin Katz co-founded Happy Head, an online provider of customized hair growth medicine prescribed by board-certified dermatologists, in 2020 and has been CEO since 2021. Benjamin trained as a nurse at the University of Pennsylvania, also studied economics there, and earned an MBA from the Wharton School. Earlier, Benjamin founded CARD.com and, in 2018, HavenColiving.com.enFri, 06 Nov 2026 15:24:04 +0000https://theexpertindex.ai/experts/healthcare/benjamin-katz/more-hair-loss-drugs-make-combination-decisions-the-hard-parthttps://theexpertindex.ai/experts/healthcare/benjamin-katz/more-hair-loss-drugs-make-combination-decisions-the-hard-partFri, 06 Nov 2026 15:24:04 +0000Benjamin KatzHealthcareAs more hair loss compounds arrive that add to existing treatments, the difficult work becomes choosing the right combination, dose, and order for each patient. Benjamin sees the Lilly and Hims GLP-1 deal as a sign that large manufacturers will partner with online prescribers. If new hair compounds arrive as add-ons, Benjamin argues, specialist dermatologists are better suited than volume platforms to design each patient's combination.https://theexpertindex.ai/experts/healthcare/benjamin-katz/health-companies-should-separate-clinical-and-business-decisionshttps://theexpertindex.ai/experts/healthcare/benjamin-katz/health-companies-should-separate-clinical-and-business-decisionsThu, 05 Nov 2026 15:26:04 +0000Benjamin KatzHealthcareHealth companies should state publicly who makes clinical decisions and who makes business decisions, because clear separation, not vertical integration, is what earns patient trust. Benjamin sees CVS splitting off its pharmacy arm as healthy, since one company acting as clinic, pharmacy, and business blurs who each decision serves. Benjamin points to Happy Head, where dermatologists alone prescribe, as a model to copy and publish.